Holen Sie sich die Stockscreener-App
0.578
9.06%
0.048
Schlusskurs vom Vortag:
$0.53
Offen:
$0.5458
24-Stunden-Volumen:
10,455
Relative Volume:
0.25
Marktkapitalisierung:
$13.67M
Einnahmen:
$12.00M
Nettoeinkommen (Verlust:
$-63.23M
KGV:
-0.0963
EPS:
-6
Netto-Cashflow:
$-43.02M
1W Leistung:
+7.04%
1M Leistung:
-45.47%
6M Leistung:
-68.92%
1J Leistung:
-34.87%
1-Tages-Spanne:
$0.53
$0.5779
1-Wochen-Bereich:
$0.5141
$0.5895
52-Wochen-Spanne:
$0.49
$2.09
Accelerate Diagnostics Inc Stock (AXDX) Company Profile
Firmenname
Accelerate Diagnostics Inc
Sektor
Branche
Telefon
303-863-8088
Adresse
3950 S. COUNTRY CLUB ROAD #470, TUCSON, AZ
Vergleichen Sie AXDX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AXDX
Accelerate Diagnostics Inc
|
0.5779 | 13.67M | 12.00M | -63.23M | -43.02M | -6.00 |
|
ABT
Abbott Laboratories
|
131.46 | 221.92B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.08 | 139.43B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
346.42 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
83.00 | 104.24B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
70.19 | 40.93B | 5.72B | 4.17B | 259.90M | 6.97 |
Accelerate Diagnostics Inc Stock (AXDX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-03-09 | Herabstufung | Craig Hallum | Buy → Hold |
| 2020-10-08 | Eingeleitet | BTIG Research | Neutral |
| 2020-08-07 | Hochstufung | Craig Hallum | Hold → Buy |
| 2019-09-27 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2018-11-07 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2018-05-24 | Eingeleitet | Craig Hallum | Hold |
| 2017-12-13 | Herabstufung | BTIG Research | Buy → Neutral |
| 2017-07-12 | Fortgesetzt | BTIG Research | Buy |
| 2016-03-24 | Eingeleitet | JP Morgan | Overweight |
| 2015-12-16 | Eingeleitet | Piper Jaffray | Overweight |
Alle ansehen
Accelerate Diagnostics Inc Aktie (AXDX) Neueste Nachrichten
Accelerate Diagnostics (NASDAQ:AXDX) Coverage Initiated by Analysts at StockNews.com - Defense World
Accelerate Diagnostics adds new independent directors - Investing.com Australia
Accelerate Diagnostics adds new independent directors By Investing.com - Investing.com Canada
Accelerate Diagnostics (AXDX) Appoints New Directors and Forms S - GuruFocus
Accelerate Diagnostics Appoints New Independent Directors - TipRanks
Accelerate Diagnostics board forms committee to exlore strategic alternatives - TipRanks
Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and Precision Medicine - Yahoo Finance
Accelerate Diagnostics CEO Jack Phillips sells $16,472 in stock - Investing.com Australia
Accelerate Diagnostics CTO sells shares worth $989 - Investing.com
Accelerate Diagnostics CTO sells shares worth $989 By Investing.com - Investing.com South Africa
Accelerate Diagnostics CEO Sells Shares to Cover Tax Obligations - TradingView
AXDX stock touches 52-week low at $0.63 amid market challenges - Investing.com India
Accelerate Diagnostics CEO Jack Phillips sells $16,472 in stock By Investing.com - Investing.com Canada
Microbial Identification Methods Market Forecasted to Grow at 6.64% CAGR, Reaching $8.16 Billion by 2030The Insight Partners - Yahoo Finance
Automotive Diagnostics Scanner Market to Accelerate Growth with Actron, Denso, Launch Tech - newstrail.com
Accelerate Diagnostics CFO sells shares worth $4,839 By Investing.com - Investing.com South Africa
Accelerate Diagnostics CFO sells shares worth $4,839 - Investing.com
Accelerate Diagnostics (NASDAQ:AXDX) Shares Pass Below 200 Day Moving Average – What’s Next? - Defense World
AXDX stock touches 52-week low at $0.73 amid market challenges By Investing.com - Investing.com South Africa
AXDX stock touches 52-week low at $0.73 amid market challenges - Investing.com Australia
Accelerate Diagnostics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Accelerate Diagnostics (NASDAQ:AXDX) Now Covered by Analysts at StockNews.com - Defense World
Accelerate Diagnostics Reports 2024 Financial Results - TipRanks
Antimicrobial Susceptibility Testing Market Expecting Huge Demand in Upcoming Years Accelerate Diagnostics - openPR.com
Accelerate Diagnostics Inc expected to post a loss of 49 cents a shareEarnings Preview - TradingView
Accelerate Diagnostics seeks FDA clearance for WAVE system By Investing.com - Investing.com Australia
Accelerate Diagnostics seeks FDA clearance for WAVE system - Investing.com India
InventHelp Inventor Develops Modified Single-Serve Coffeemaker (KXK-162) - The Malaysian Reserve
Accelerate Diagnostics Submits WAVE System and Gram-Negative Positive Blood Culture Menu to the FDA for 510(k) Clearance - PR Newswire
Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2024 Financial Results - PR Newswire
Accelerate Diagnostics Inc. (AXDX) reports earnings - Quartz
Accelerate Diagnostics, Inc SEC 10-K Report - TradingView
Accelerate Diagnostics (AXDX) Expected to Announce Quarterly Earnings on Thursday - Defense World
StockNews.com Initiates Coverage on Accelerate Diagnostics (NASDAQ:AXDX) - Defense World
Major Microbial Identification Market Trend 2025-2034: Automated Systems Transform Microbial Identification... - WhaTech
Accelerate Diagnostics, Inc. to Host Earnings Call - ACCESS Newswire
Accelerate Diagnostics (NASDAQ:AXDX) Earns Hold Rating from Analysts at StockNews.com - Defense World
Accelerate Diagnostics CFO Patience David sells $583 in stock By Investing.com - Investing.com South Africa
Investor Network: Accelerate Diagnostics, Inc. to Host Earnings Call - ACCESS Newswire
Accelerate Diagnostics CFO Patience David sells $583 in stock - Investing.com
Merger Agreement with BioSymetrics to Accelerate Biomarker Identification, Enhance Drug Discovery and Expand Precision Medicine Applications in Advanced Cancer Diagnosis and Treatment | FinancialContent Business Page - Financial Content
Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine - The Manila Times
Finanzdaten der Accelerate Diagnostics Inc-Aktie (AXDX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Accelerate Diagnostics Inc-Aktie (AXDX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Phillips Jack | Chief Executive Officer |
Apr 04 '25 |
Sale |
0.65 |
25,343 |
16,473 |
191,374 |
| Mertz Larry Michael | Chief Technology Officer |
Apr 04 '25 |
Option Exercise |
0.00 |
4,298 |
0 |
86,326 |
| Mertz Larry Michael | Chief Technology Officer |
Apr 04 '25 |
Sale |
0.65 |
1,523 |
990 |
84,803 |
| Patience David | Chief Financial Officer |
Apr 01 '25 |
Option Exercise |
0.00 |
20,000 |
0 |
71,384 |
| Patience David | Chief Financial Officer |
Apr 01 '25 |
Sale |
0.71 |
6,816 |
4,839 |
64,568 |
| Patience David | Chief Financial Officer |
Feb 26 '25 |
Option Exercise |
0.00 |
1,500 |
0 |
51,919 |
| Patience David | Chief Financial Officer |
Feb 26 '25 |
Sale |
1.09 |
535 |
583 |
51,384 |
| Phillips Jack | Chief Executive Officer |
Feb 01 '25 |
Option Exercise |
0.00 |
1,000 |
0 |
163,919 |
| Phillips Jack | Chief Executive Officer |
Feb 03 '25 |
Sale |
1.35 |
485 |
655 |
163,434 |
| PATIENCE JOHN | Director |
Dec 03 '24 |
Buy |
1.57 |
200,000 |
314,000 |
653,224 |
0.85%
0.85%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):